BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology 2007;46:1312-3. [PMID: 17894318 DOI: 10.1002/hep.21816] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liao B, Zhang F, Lin S, He H, Liu Y, Zhang J, Xu Y, Yi J, Chen Y, Liu H. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China. PLoS One. 2014;9:e115888. [PMID: 25532128 DOI: 10.1371/journal.pone.0115888] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
2 Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol 2011;83:1172-7. [DOI: 10.1002/jmv.22095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
3 Niro GA, Smedile A, Ippolito AM, Ciancio A, Fontana R, Olivero A, Valvano MR, Abate ML, Gioffreda D, Caviglia GP, Rizzetto M, Andriulli A. Outcome of chronic delta hepatitis in Italy: a long-term cohort study. J Hepatol. 2010;53:834-840. [PMID: 20800919 DOI: 10.1016/j.jhep.2010.06.008] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
4 Milana M, Angelico M. The evolving scenario of HBV infection and disease: A never-ending story. Dig Liver Dis 2019;51:443-4. [PMID: 30470554 DOI: 10.1016/j.dld.2018.10.017] [Reference Citation Analysis]
5 Ciancio A, Rizzetto M. Chronic hepatitis D at a standstill: where do we go from here? Nat Rev Gastroenterol Hepatol. 2014;11:68-71. [PMID: 24019153 DOI: 10.1038/nrgastro.2013.164] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
6 Brancaccio G, Fasano M, Grossi A, Santantonio TA, Gaeta GB. Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir. Aliment Pharmacol Ther. 2019;49:1071-1076. [PMID: 30793345 DOI: 10.1111/apt.15188] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
7 Da BL, Heller T, Koh C. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterol Rep (Oxf) 2019;7:231-45. [PMID: 32477569 DOI: 10.1093/gastro/goz023] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50:1043-1050. [PMID: 19285743 DOI: 10.1016/j.jhep.2009.01.004] [Cited by in Crossref: 155] [Cited by in F6Publishing: 117] [Article Influence: 11.9] [Reference Citation Analysis]
9 Aldabe R, Suárez-Amarán L, Usai C, González-Aseguinolaza G. Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions. Pathogens. 2015;4:46-65. [PMID: 25686091 DOI: 10.3390/pathogens4010046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
10 William Tong CY, Asher R, Toby M, Ngui SL, Tettmar K, Ijaz S, Tedder R, Kulasegaram R, Wilkinson M, Wong T. A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London. J Infect 2013;66:521-7. [PMID: 23466596 DOI: 10.1016/j.jinf.2013.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
11 Stroffolini T, Ciancio A, Furlan C, Vinci M, Fontana R, Russello M, Colloredo G, Morisco F, Coppola N, Babudieri S, Ferrigno L, Sagnelli C, Sagnelli E. Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium. J Viral Hepat 2020;27:941-7. [PMID: 32338810 DOI: 10.1111/jvh.13310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Madejón A, Romero M, Hernández &, García-Sánchez A, Sánchez-Carrillo M, Olveira A, García-Samaniego J. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype. World J Gastroenterol 2016; 22(11): 3165-3174 [PMID: 27003993 DOI: 10.3748/wjg.v22.i11.3165] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Kondili LA, Cuko L, Chionne P, Candido A, Madonna E, Dentico P, Resuli B, Taliani G, Brunetto MR, Rapicetta M. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol. 2010;22:167-171. [PMID: 19734797 DOI: 10.1097/meg.0b013e328330d410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Stroffolini T, Sagnelli E, Sagnelli C, Russello M, De Luca M, Rosina F, Cacopardo B, Brancaccio G, Furlan C, Gaeta GB, Licata A, Almasio PL;  behalf of EPACRON study group. Hepatitis delta infection in Italian patients: towards the end of the story? Infection. 2017;45:277-281. [PMID: 27817147 DOI: 10.1007/s15010-016-0956-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
15 Coppola N, Alessio L, Onorato L, Sagnelli C, Sagnelli E, Pisaturo M. HDV infection in immigrant populations. J Med Virol 2019;91:2049-58. [PMID: 31429940 DOI: 10.1002/jmv.25570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136:1629-1638. [PMID: 19208358 DOI: 10.1053/j.gastro.2009.01.052] [Cited by in Crossref: 184] [Cited by in F6Publishing: 155] [Article Influence: 14.2] [Reference Citation Analysis]
17 Ferrante ND, Lo Re V 3rd. Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection. Curr HIV/AIDS Rep. 2020;17:405-414. [PMID: 32607773 DOI: 10.1007/s11904-020-00508-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Niro GA, Fontana R, Ippolito AM, Andriulli A. Epidemiology and diagnosis of hepatitis D virus. Future Virology 2012;7:709-17. [DOI: 10.2217/fvl.12.61] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. Journal of Viral Hepatitis 2009;16:883-94. [DOI: 10.1111/j.1365-2893.2009.01144.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
20 Wedemeyer H. Re-emerging interest in hepatitis delta: New insights into the dynamic interplay between HBV and HDV. Journal of Hepatology 2010;52:627-9. [DOI: 10.1016/j.jhep.2010.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
21 Hofmann J, Frenzel K, Minh BQ, von Haeseler A, Edelmann A, Ross SR, Berg T, Krüger DH, Meisel H. Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagnostic Microbiology and Infectious Disease 2010;67:172-9. [DOI: 10.1016/j.diagmicrobio.2010.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
22 Yurdaydın C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010;17:749-56. [PMID: 20723036 DOI: 10.1111/j.1365-2893.2010.01353.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 7.0] [Reference Citation Analysis]
23 Stroffolini T, Morisco F, Ferrigno L, Pontillo G, Iantosca G, Cossiga V, Crateri S, Tosti ME; SEIEVA collaborating group. Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign. J Viral Hepat 2021. [PMID: 34585819 DOI: 10.1111/jvh.13620] [Reference Citation Analysis]
24 De Paschale M, Manco MT, Belvisi L, Magnani C, Re T, Viganò P, Biagiotti S, Capelli F, Mazzone A, Baldacci MP, Ferrara A, Neri AL, Guastoni CM, Bonazzina RA, Brando B, Clerici P. Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy. Infection 2012;40:485-91. [PMID: 22367777 DOI: 10.1007/s15010-012-0247-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
25 Alves C, Branco C, Cunha C. Hepatitis delta virus: a peculiar virus. Adv Virol 2013;2013:560105. [PMID: 24198831 DOI: 10.1155/2013/560105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
26 Brancaccio G, Shanyinde M, Puoti M, Gaeta GB, Monforte AD, Vergori A, Rusconi S, Mazzarelli A, Castagna A, Antinori A, Cozzi-lepri A. Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy. Pathogens and Global Health. [DOI: 10.1080/20477724.2022.2047551] [Reference Citation Analysis]
27 Heidrich B, Manns MP, Wedemeyer H. Treatment options for hepatitis delta virus infection. Curr Infect Dis Rep. 2013;15:31-38. [PMID: 23242761 DOI: 10.1007/s11908-012-0307-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.2] [Reference Citation Analysis]
28 Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378:73-85. [PMID: 21511329 DOI: 10.1016/s0140-6736(10)61931-9] [Cited by in Crossref: 316] [Cited by in F6Publishing: 125] [Article Influence: 28.7] [Reference Citation Analysis]
29 Brancaccio G, Gaeta GB. Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfection. Int J Antimicrob Agents 2019;54:697-701. [PMID: 31541699 DOI: 10.1016/j.ijantimicag.2019.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Brancaccio G, Nardi A, Madonia S, Fasano M, Verucchi G, Massari M, Maimone S, Contini C, Levantesi F, Alfieri A, Gavrila C, Andreone P, Milella M, Gaeta GB. The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort. Dig Liver Dis 2019;51:438-42. [PMID: 30314950 DOI: 10.1016/j.dld.2018.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Contini C, Badia L, Cultrera R, Grilli A, De Togni A. Epidemiological, clinical and laboratory features of chronic hepatitis B infection in a cohort of immigrant and Italian patients from Ferrara, Italy. Annals of Hepatology 2012;11:862-9. [DOI: 10.1016/s1665-2681(19)31411-5] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]